Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Markets & Finance

JP Morgan Downgrades Alcon to 'Neutral'

JP Morgan downgraded Alcon (ACL) to neutral from overweight.

Analyst Michael Weinstein believes prospects remain relatively upbeat for the vision care pharmaceuticals company. Still, after a strong 2002 he sees greater upside potential with comparable companies that offer higher top-line growth potential and more meaningful leverage through the operating income line.

Weinstein notes his MedTech strategy for 2003 favors higher beta cardiovascular names over orthopedic companies and more traditional medical suppliers. As a result, his Alcon downgrade is in light of a recent upgrade of cardiovascular company St. Jude Medical, which he named his Top Pick for 2003.

blog comments powered by Disqus